Understand how WHO disease surveillance provides early market warnings. Track GOARN and IHR 2005 to find investment opportunities.
Editorial Team
·
How are inflation, interest rates, and geopolitics reshaping insurance? Underwriters face 15-20% higher property limits. Learn what's next.
·
Pharma faces high costs. See 5 ways to improve drug development ROI, like using AI to cut early-phase costs by up to 30%, speeding new treatments.
·
Public opinion is split on CRISPR gene editing. Learn why costs exceed $1M and how regulations grapple with this powerful medicine.
·
What makes a city a top talent hub in 2026? See how cities compete for corporate HQs with incentives, urban plans, and hybrid work readiness.
·
·
7 min read
Global oil prices surged 40%, threatening businesses like Global Threads. Learn how to prepare for sudden economic shocks with key strategies.
·
·
7 min read
Only 15% of critical medicines reach low-income nations, per WHO. Learn why global market access fails and what's next for life-saving treatments.
·
·
7 min read
CRISPR could cut livestock antibiotic use and carbon footprint. See how gene-edited animals may reshape food production by 2030.
·
·
6 min read
CRISPR investment hits $15B by 2030. See how NIH funding and VC are driving gene editing therapies, diagnostics, and future challenges.
·
·
9 min read
CTV programmatic ad spending hits $47.5B by 2027. Understand this market shift, why it matters for advertisers, and what's next for ad tech.
·
·
5 min read
